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Animals with  genetically determined  defects  in  immune function  have provided 
valuable models for the elucidation of the mechanisms of normal immune responses. 
Thus, the CBA/N mouse, which bears a mutant X  chromosomal gene (xid), has been 
of great value in understanding  functional and developmental heterogeneity among 
B  lymphocytes (1).  Mice which  are homozygous or hemizygous for the xid gene are 
unresponsive  to  a  set  of  thymus-independent  (TI) 1  antigens,  of  which  trinitro- 
phenylated (TNP)-Ficoll is the prototype (2). The TI antigens to which such mice are 
unresponsive  have been  designated  TI-2 antigens  (3).  By contrast,  these  mice can 
respond  to another set of TI antigens,  TI-1  antigens,  of which  TNP-Brucella  abortus 
(TNP-BA)  is  the  prototype,  and  to  many thymus-dependent  (TD)  antigens  (2-5). 
Furthermore, splenic B lymphocytes from defective mice are stimulated to proliferate 
and to synthesize antibody by polyclonal B-cell activators, such as lipopolysaccharide 
(LPS)  (2, 4) and Nocardia water-soluble mitogen (NWSM)  (6), although they tend to 
do so most efficiently at high cell density and in the presence of fetal calf serum (2). 
B  lymphocytes  from  mice  with  the  CBA/N  immune  defect  have  low  ratios  of 
membrane  IgD  (mIgD)  to  membrane  IgM  (mIgM)  when  compared  with  normal 
controls  (7)  and  fail to express the  B-lymphocyte differentiation  antigens  Lyb3  (8), 
Lyb5 (9), and Lyb7 (10). It has been proposed that their defect stems from the absence 
of  a  subset  of  B  lymphocytes  which  are  either  mature  members  of a  single,  B 
lymphocyte lineage or which are in a  lineage separate from the B lymphocytes that 
respond to TI-1 antigens  (1). 
The C3H/HeJ mouse possesses a  mutant gene Lps a  (11), located on chromosome 
4  (12),  that  leads  to  unresponsiveness  to  the  immunological  and  pharmacological 
1  Abbreviations used in this paper: BC, backcross; CFA, complete Freund's adjuvant; Con A, concanavalin 
A;  DNP-KLH, 2,4-dinitrophenyl-conjugated keyhole limpet hemocyanin; F-,  unresponsive to trinitro- 
phenylated Ficoll; F  +, responsive  to trinitrophenylated Ficoll; IC, intercross; K-, unresponsive  to lipopoly- 
saccharide from Escherichia coli K235; K  +,  responsive to  lipopolysaccharide from E.  coli K235; LPS, 
lipopnlysaccharide; LPS 0111:B4, LPS from E. coli 0Ill:B4; LPS K235, LPS from E. coli K235; mlgD, 
membrane IgD; mIgM, membrane IgM; NWSM, Nocardia water-soluble mitogen; PFC, plaque-forming 
cell(s); RBC, reverse backcross; SD, synergistic defect; SD-, lacking the SD phenotype; SD  B', partial SD 
phenotype; TD, thymus dependent; TI, thymus independent; TNP, trinitrophenyl; TNP-BA, trinitro- 
phenylated Brucella abortus; TNP-FicoI1,  trinitrophenylated Ficoll; TNP-LPS, trinitrophenylated LPS 0111: 
B4; TNP-levan, trinitrophenylated levan. 
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effects of endotoxin.  Thus,  C3H/HeJ  lymphocytes fail  to  proliferate  or  synthesize 
antibody  when  exposed  to  LPS  preparations  which  are  not  contaminated  with 
mitogenic bacterial lipoproteins or proteins (13). In addition, these mice are insensitive 
to the macrophage-mediated adjuvant activities of LPS (14). Immunological activities 
stimulated by agents other than LPS are normal in these mice. 
We have recently begun to investigate the immune responsiveness of mice that are 
crosses between the CBA/N and C3H/HeJ strains.  We observed that some Fa male 
mice  from  the  cross  of CBA/N  female  and  C3H/HeJ  male  parents  and  many 
backcross male mice resulting from matings of FI female and C3H/HeJ male parents 
exhibit  more profound immune defects  than  either  parental  strain.  Such mice are 
unresponsive, in vitro, to TI-1 as well as to TI-2 antigens, do not exhibit proliferative 
responses  to several  B-cell mitogens, and  have an  abnormality in  the  mIgD:mIgM 
ratio  on  their  B  lymphocytes which  is  substantially  more  striking  than  that  of 
CBA/N (J. J.  Mond, C.  Bona, S.  Kessler, I. Scher, and W.  E.  Paul.  Manuscript  in 
preparation.). 
This  synergistic,  genetically  determined  immune  defect  of B  lymphocytes does 
depend on the xid gene as crosses of CBA/CaN female mice, which are  + /  +  at the 
xid locus, to C3H/HeJ males and subsequent backcrossing to C3H/HeJ males fails to 
yield  progeny which  are  unresponsive  to  TI-1  antigens  or  to  B-cell  mitogens.  By 
contrast, the defective gene at the Lps locus (Lps a)  is not required for the expression 
of the synergistic defect as backcrosses obtained from matings of (CBA/N ×  C3H/ 
HeN)F1 mice ×  C3H/HeN mice are as defective as similar mice prepared using C3H/ 
HeJ  parents,  although  the  C3H/HeN strain  has  a  normal  allele  at  the  Lps  locus 
(Lps"). 
Materials and Methods 
Mice.  CBA/N,  CBA/CaN,  and  C3H/HeN  mice  were  obtained  from  the  Division  of 
Research Services, National Institutes of Health, Bethesda, Md. C3H/HeJ mice were purchased 
from The Jackson Laboratory (Bar Harbor, Maine).  F1 hybrids  from the matings  of CBA/N 
females with C3H/HeJ males [(CBA/N × C3H/HeJ)F1], from CBA/CaN females with C3H/ 
HeJ males  [(CBA/CaN ×  C3H/HeJ)F@ and  from CBA/N females with  C3H/HeN males 
[(CBA/N ×  C3H/HeN)F1] were prepared in our animal facility. F1 female mice were mated 
with  C3H/HeJ or C3H/HeN male mice  to yield  backcross mice. Mice  from  the backcross 
[(CBA/N × C3H/HeJ)F1 × C3H/HeJ] are referred to BC. 1 mice. This breeding  scheme and 
the genotypes of progeny are presented  in Fig. 1. 
Antigens and Mitogens.  TNP derivatives  of aminoethylcarbamylrhethyl  Ficoll, (Pharmacia 
Fine Chemicals, Div. of Pharmacia, Inc., Piscataway,  N. J.), B. abortus, Escherichia coli 0111:B4 
LPS (TNP-LPS),  and NWSM (TNP-NWSM) were prepared as previously described (4, 5, 15- 
17). 2,4-dinitrophenyl-conjugated  keyhole limpet  hemocyanin (DNP-KLH) was provided  by 
Dr. Kathryn Stein, National Institute of Allergy and Infectious Diseases, National Institutes  of 
Health; it contained 10 groups per  100,000 dahons. 
LPS from E.  coli K235,  (LPS  K235),  the  kind  gift of Dr.  David  Rosenstreich,  National 
Institute of Dental  Research,  National  Institutes  of Health,  was prepared  according to the 
procedure  of Westphal  et  al.  (18). This preparation lacks detectable  quantities  of mitogenic 
lipoprotein  and protein  and fails to stimulate  spleen cells from C3H/HeJ mice. LPS from E. 
coli 0111 :B4, (LPS 0111 :B4), prepared according to the Boivin procedure, was purchased  from 
Difco Laboratories  (Detroit, Mich.). It has been reported  to be contaminated with lipoprotein 
mitogen and can stimulate  proliferative and plaque-forming  cell (PFC) responses by C3H/HeJ 
spleen  cells. Lipoprotein  extracted  from E.  coli was a  gift  from  Dr.  Bressler, University  of 
Tiibingen,  Tfibingen,  West  Germany.  NWSM was prepared  according to the technique of 226  SYNERGISTIC  B-CELL  DEFECT 
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Fro.  1.  Breeding scheme for the production of BC.I  mice. 
Ciorbaru et al.  (19). Concanavalin A (Con A) was obtained from Pharmacia Fine Chemicals, 
Div. of Pharmacia, Inc. 
In  Vitro Antibody and Proliferative Responses.  Spleen  cells  (5  X  105) from various mice were 
cultured in microtiter plates  (tissue  culture, cluster 36, Costar,  Data Packaging, Cambridge, 
Mass.)  with TNP-Ficoll (10  -a/Lg/ml), TNP-BA (1:100 dilution of stock), TNP-LPS (5/tg/ml), 
and TNP-NWSM (3 #g/ml), as described previously (5,  17). Anti-TNP PFC responses  to TNP- 
Ficoll  and trinitrophenylated levan (TNP-levan) were measured on day 4; responses  to TNP- 
BA, TNP-LPS, and TNP-NWSM were measured either on da~ 3 or day 4. 
Proliferative responses  were measured by culturing 2.5 ×  10  spleen cells in microtiter wells 
with LPS K235 (25/tg/ml), LPS 0111 :B4 (25 #g/ml), NWSM (50 #g/ml), lipoproteins  (3/~g/ 
ml),  or  Con  A  (2  #g/ml),  as  previously  described  (5). Uptake  of tritiated  thymidine  was 
determined on the third day of culture. 
Results 
Responses of BC. 1 Male Spleen  Cells to TI Antigens and Mitogens.  BC. 1 male mice were 
prepared  by backcrossing  (CBA/N  ×  C3H/HeJ)Fx  female  mice to C3H/HeJ  male 
mice, as shown in Fig.  1. Male mice from two consecutive litters were killed and their 
spleen cells tested  in vitro for anti-TNP antibody responses to TNP TI antigens and 
for proliferative responses to various B-cell mitogens. As controls, cells from C3H/HeJ 
males, CBA/N females, and Fx females were also studied. 
As shown in Table I, F1 female spleen cells yield substantial  PFC responses to TNP- 
Ficoll,  TNP-BA,  TNP-LPS,  and  TNP-NWSM.  They  develop  strong  proliferative 
responses  to  both  LPS  K235  and  LPS  0111:B4,  lipoprotein,  NWSM,  and  Con  A. 
CBA/N spleen cells fail to respond to TNP-Ficoll and C3H/HeJ  cells to LPS K235, 
as anticipated  from their known genetic defects. Both CBA/N and C3H/HeJ  spleen 
cells respond quite normally to the other stimulants.  Spleen cells  from four of seven 
BC. 1 male mice make no anti-TNP antibody response to TNP-Ficoll. This is expected 
because one-half of these mice should be hemizygous for the xid gene, the hallmark of 
which  is  unresponsiveness  to TNP-FicoI1.  However,  spleen  cells  from three  of these 
mice also failed  to give in vitro antioTNP responses to any of the TNP TI antigens. 
Spleen cells from six of seven BC. 1 male mice failed to proliferate in response to LPS 
K235. Of these, four were also unresponsive to LPS 0111 :B4, lipoprotein, and NWSM. 
Three  of  the  four  LPS  0111:B4-unresponsive  mice  were  the  animals  that  were 
unresponsive to all TNP TI antigens. Thus, we concluded that four of the seven BC. 1 
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TABLE I 
Responses of BC. 1 Male Spleen Cells to TI Antigens and Mitogens 
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Response  to TNP TI antigens (No. of anti-TNP 
PFC/culture) 
Response to B-lymphocyte mitogens (uptake of tritiated thymidine)* 
Medium  TNP-Fi-  TNP-  TNP-  TNP-  Medium  K235  LPS  Lipopro-  NWSM  Con A 
coil  BA  LPS  NWSM  0111 :B4  teln 
cpm 
C3HHeJ male  6  152  396  166  154  (5,887):~  2,338  82,190  80,551  29,199  351,296 
CBA/N female  0  0  154  78  310  (4,242)  25,230  90,482  49,723  37,870  279,988 
FI female  20  138  584  146  248  (10,879)  88,417  101,321  106,121  48,830  356,471 
BC.1 male No. 
1  0  0  4  10  0  (1,034)  0  1,746  39  0  233,254 
2  20  104  372  50  230  (2,228)  80,910  138,922  102,872  26,054  291,576 
3  4  0  52  92  106  (277)  0  2,915  2,994  694  400,789 
4  0  88  190  62  12  (2,276)  1,014  29,767  30,585  5,657  150,155 
5  0  0  0  6  2  (563)  0  709  261  362  52,737 
6  0  0  0  0  0  (407)  27  2,223  1,171  1,020  58,805 
7  0  26  126  38  72  (I,113)  0  62,647  46,295  97,325  218,242 
* Counts per minute of tritiated thymidine taken up by cells from cultures exposed  to a  mitogen minus the counts per minute of tritiated 
taken up by cells from cultures exposed to medium only. 
:~ Values in parentheses are uptake of tritiated thymidine by cells exposed to medium only. 
thymidine 
unresponsive to any of the B-cell stimulants we tested. We refer to the failure of BC. 1 
mice to respond to B-cell mitogens and to TI-1 antigens as a synergistic defect (SD). 
Mice such as animals  1, 5, and 6, which are unresponsive to all B-cell mitogens and 
TI-1 antigens, are designated SD  +, whereas mice, such as animal 3, which respond to 
TI-1 antigens but either not at all or only poorly to LPS 011 l:B4, lipoproteins, and 
NWSM, are considered to express a  partial SD phenotype (SDP). 
All  the  BC.1  mice  tested  responded  to  Con  A,  indicating  that  SD  +  mice  are 
responsive to some lymphocyte stimulants. 
Because of these results, we examined in vitro proliferative and antibody responses 
in a  large series of BC. 1 male mice as well as in the parental strains, F1 hybrids, and 
BC. 1 females. In general, spleen cells from C3H/HeJ, CBA/N,  (C3H/HeJ ×  CBA/ 
N)F1  females, and  BC.1  females gave good proliferative responses to  LPS 0111:B4 
and NWSM  (Table II) and good antibody responses to TNP-BA and TNP-NWSM 
(Table III). As expected, spleen cells from C3H/HeJ mice did  not  respond  to LPS 
K235, whereas CBA/N and F1 female cells responded well to this stimulant. CBA/N 
spleen  cells  did  not  produce  anti-TNP  antibody  to TNP-Ficoll,  but  C3H/HeJ,  F1 
female, and BC. 1 females were all good responders.  F1  male mice, which  are hemi- 
zygous for the xid gene, were unresponsive to TNP-Ficoll.  However, approximately 
one-half were also unresponsive to  LPS  K235  and  LPS 0111:B4,  and  only weakly 
responsive to  NWSM,  TNP-BA,  and  TNP-NWSM.  Of BC.1  males,  32  of 51  were 
unresponsive  to  TNP-Ficoll,  and  approximately one-half failed  to  respond  to  the 
other stimulants. In general, individual BC. 1 male mice expressed a good correlation 
in  their  proliferative  response  to  LPS  0111:B4  and  in  their  anti-TNP  antibody 
response to TNP-BA (Fig. 2). This indicates that either of the two responses could be 
used  to  assign  the  SD  phenotype.  Wherever  possible,  we  have  evaluated  both 
characteristics in all animals studied and we assign the SD  ÷ phenotype only to those 
in which both responses are absent. 
Using this approach, we phenotyped 41 BC. 1 male mice upon whom all of our tests 
were performed. Because one-half of the males should have inherited an xid gene, we 228  SYNERGISTIC B-CELL DEFECT 
TABLE  II 
Responsiveness of Spleen Cells from BC. l  Mice to B-Cell Mitogens 
Mice 
No. of responders/total* 
E. coil' LPS 
LPS 0111:B4  LPS K235  (Boivin) 
NWSM 
C3H/HeJ  1/13  11/14  9/9 
CBA/N  11/11  13/13  8/8 
F1 female  9/9  9/9  8/8 
F1 male  10/20  9/19  16/16 
BC. 1 female  ND  4/6  6/6 
BC. 1 male  8/44  17/46  25/48 
* Responders are defined as cultures in which the counts per minute were 
>3,000. ND, not done. 
TABLE  III 
Responsiveness of Spleen Cells from BC. 1 Mice to TI Antigens 
Mice 
No. of responders/total* 
TNP-Ficoll  TNP-BA  TNP-NWSM 
C3H/HeJ  14/15  15/15  12/12 
CBA/N  1/16  15/15  11/12 
F1 female  8/8  10/10  9/9 
F1 male  0/11  18/20  16/21 
BC. 1 female  6/6  7/7  7/7 
BC. 1 male  19/51  23/41  25/44 
* Responders are defined as cultures in which 20 or more anti-TNP PFC per 
culture were obtained. 
anticipated that  50%  would be  unresponsive to  TNP-Ficoll (F-).  In fact,  24  of 41 
(58%)  were F- (Table IV). Similarly, we anticipated that one-half of the mice would 
be homozygous for the Lps  a gene and thus unresponsive to LPS K235  (K-). In fact, 
32/41  (78%)  were  K-.  Among mice responsive to  TNP-Ficoll (F+),  approximately 
one-half (9/17)  were  K-.  However, among F- mice, 23/24 were  K- and all 23  K- 
individuals expressed  either  the  SD  +  or  SD  p phenotype.  This suggests  that  in  the 
presence of the xid defect, a  C3H gene present in the heterozygous form can lead to 
the expression of the  SD  and that  such  animals may fail to  respond to  LPS  K235 
because of their SD phenotype even if they possess an Lps n gene. Indeed, the finding 
in Tables II and III that approximately one-half of the F1 males expressed an SO  p or 
SD  + phenotype is consistent with this view. It does appear however that the expression 
of the SD phenotype in F- BC.1 male mice is much more frequent than in F- F1 male 
mice. 
Mice with SD  + phenotype, although unresponsive in vitro to B-cell mitogens and 
to both TI-1 and TI-2 antigens, can make secondary anti-TNP antibody responses to 
the TD antigen DNP-KLH. Thus, a  group of 16 BC. 1 male mice were immunized 
with 10 #g of DNP-KLH emulsified in complete Freund's adjuvant (CFA). 1 mo later, 
they received a  secondary immunization with  10 #g of DNP-KLH in saline. Direct 
and facilitated splenic anti-TNP PFC were measured 5 d  later. These mice were also FIG.  2. 
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Responses of spleen cells from individual BC.1 male mice to TNP-BA and to LPS 0111: 
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TABLE IV 
Frequency of Phenotypes in BC 1 Male Mice 
Genotype 
Anticipated  Observed (n = 41) 
Phenotype  Frequency  Phenotype  Frequency 
+ / Y, Lps"/Lps d  F+K  +  0.25  F+K  ÷  0.20 
+/Y, Lpsa/Lps  d  F+K  -  0.25  F*K  0.22 
xid/Y, Lps"/Lps a  F-K  +  0.25  P-K  +  0.02 
xid/Y, Lpsa/Lps  d  F-K-  0.25  F-K-  0.56 
F-K-, SD  ÷  0.39 
F-K-, SD  p  0.17 
typed for the SD phenotype by measuring the proliferative response of their spleen 
cells to LPS 011 l:B4. As shown in Table V, the SD  + BC. 1 male mice made responses 
equivalent to those of their littermates without the SD  + phenotype (SD-). 
The xid but  not  the Lps a Gene is Required for the Expression  of the  SD Phenotype.  The 
observation that  23  of 24  F- BC.1  male mice were also  K- and expressed either a 
partial or complete SD and that  some Ft  male mice were  SD  +,  suggested  that  the 
C3H gene(s) involved did not have to be present in the homozygous form. To examine 
this more closely, we first wished to determine whether the SD phenotype depended 
on the presence of the Lps a gene in the homozygous form. Accordingly, a  BC. 1 SD  ÷ 
male was crossed to a  C3H/HeJ  female (Table VI). Because none of the progeny of 
this cross should be F-, it should be possible to evaluate the presence of the Lps" gene 
simply by determining proliferative response of the progeny to LPS K235. In fact, all 
seven of the progeny were F +, as expected, and of the six tested, all were responsive to 
LPS K235  (K+). Thus, the BC.1  SD  + male parent must have possessed a  Lps ~ gene 
and homozygosity for the defective gene at  the Lps locus is not required for the SD 
phenotype. 
To determine whether the Lps a gene, even in a heterozygous form, was required for 
the SD phenotype, we prepared BC. 1 male mice by crossing (CBA/N ×  C3H/HeN)F1 230  SYNERGISTIC B-CELL DEFECT 
TABLE  V 
Secondary Antibody Responses of BC. 1 Male Mice to DNP-KLH 
Mice  Responsiveness 
to LPS 01 ll:B4 
Anti-TNP PFC/IO  6 cells 
Direct  Indirect 
C3H/HeJ male  +  10  108 
CBA/N female  +  39  220 
F1 male  +  30  353 
BC.1 male [8]*  +  60 (t.5)~:  309 (1.5) 
BC.1 male [81  -  51  (t.8)  646 (1.5) 
Individual C3H/HeJ, CBA/N, F1 male, and  16 BC.1 male mice were immunized 
with 10 #g of DNP-KLH emulsified  in CFA. 1 mo later,  they received a secondary 
immunization with 10#g of DNP-KLH in saline. 5 d later, the mice were killed and 
their spleens removed. A portion was used to measure  direct and indirect anti-TNP 
PFC and the remainder were cultured with LPS 011 I:B4. Of the 16 BC. 1 mice, 8 
were responsive and 8 were unresponsive  to this LPS. 
Number of animals is in brackets. 
Geometric mean; relative SE in parentheses. 
TABLE  VI 
Responsiveness of Spleen Cells from  Various Backcross Progeny to TNP TI-1 and TI-2 Antigens and B- 
Cell Mitogens 
Male progeny from crosses of 
Responders/tot al 
TNP-Fi-  LPS  LPS  TNP-BA  coil  K235  0111:B4 
C3H/HeJ  x  BC. 1 SD  +  7/7  6/6  6/6  5/5 
( + / +, ICsd/lCs 't) (xid/Y, I~ps'~/Lps  d or l.psd/14s ") 
(CBA/N X C3H/HeN)F~  X  C3H/HeN  11/24  16/24  13/24  13/24 
(xid/ +, Lps"/Lps")  ( +/Y, Lps "/Lps") 
(CBA/CaN × C3H/HeJ)F1  ×  C3H/HeJ  11/11  10/10  8/10  10/10 
( +/+, Lpsn/Lps a)  (+/Y, Lpsa/Lps a) 
females  with  C3H/HeN  males.  The  C3H/HeN  strain  is  similar  to  the  C3H/HeJ 
strain but it possesses normal allelles at the Lps locus. As shown in Table VII,  13 of 24 
BC. t  male  mice were F-,  as expected.  However,  11  of 24 were unresponsive  to  LPS 
K235  and  LPS  0111:B4  and  8  of 24  failed  to  respond  to  TNP-BA.  Thus,  the  Lps a 
gene is not required  for either the SD  p or SD  + phenotypes.  However, we should  note 
that  none  of the  (CBA/N  X  C3H/HeN)F1  males  we have studied  expressed  an  SD 
phenotype,  suggesting that the Lps a gene may make some contribution  to the SD.  By 
contrast,  the  xid  gene  appears  essential  for  the  expression  of the  synergistic  defect. 
BC.1  male  mice were prepared  by crossing (CBA/CaN  X  C3H/HeJ)Ft  female mice 
to C3H/HeJ  males. CAB/CaN  mice are genetically similar to CBA/N  mice but  they 
possess a  +  allele at the xid locus. BC. 1 male mice from this cross respond normally to 
TNP-FicoI1, TNP-BA,  and  to LPS 0111:B4.  2  of 10 were unresponsive  to LPS K235, 
presumably  because  they were homozygous for the Lps a gene. 
As an initial step in attempting to determine the nature of the C3H  influence which 
led to the appearance of the SD phenotype i 9  the presence of the xid defect, we crossed 
a  BC. 1 SD  + male mouse to a  CBA/N  female and  then  intercrossed  the progeny.  We CONSTANTIN BONA, JAMES J.  MOND,  AND WILLIAM  E.  PAUL 
TABLE  VII 
Responsiveness of Spleen Cells  from Reverse Backcross and Intercross Progeny to TNP TI-I 
and TI-2 Antigens and B-Cell Mitogens 
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Progeny of crosses of*  Sex 
No. of responders/total 
TNP-Fi-  TNP-  LPS  LPS 
coil  BA  K235  0111 :B4 
CBA/N X BC.I SD  ÷  M  0/2  0/2  0/2  0/2 
F  0/4  4/4¶  4/4¶  4/4¶ 
RBC.SD  p ×  RBC.SD+~:  M  0/5  4/5  2/5  2/5 
F  0/5  4/5  3/5  3/5 
IC.1 SD  p x  IC.i SDP§  M  0/5  2/4  0/5  0/5 
F  0/6  3/6  0/6  0/6 
IC.2 SD  +¢p~ x  IC.2 SD+I[  M  0/4  0/1  0/4  0/4 
F  0/7  0/5  0/7  0/7 
* The phenotypes of parents were determined after they had been mated and  had 
produced progeny. 
:~ RBC mice are progeny from CBA/N ×  BC. 1 SD  ÷ mating. 
§ IC. 1 mice are progeny from matings of RBC.SD  p ×  RBC.SD  + mice. IC.2 mice are 
progeny from matings of IC.I SD  p ×  [C. 1 SD  p mice. 
[I A single  IC.2 SD  ÷ male was crossed  to two IC.2  females, one of which was later 
typed as SD  + and the other as SD  p, Two litters were studied for responsiveness  to 
TNP-FicoII and to LPS K235 and LPS 011 l:B4. Only the first litter was tested  for 
responsiveness to TNP-BA. 
¶ Two of the four mice gave very weak, although positive, responses to TNP-BA, LPS 
K235, and LPS 0111 :B4. They were typed as SD  p. 
wished  to  determine  whether  the  SD  phenotype  could  be  expressed  outside  of an 
intact  C3H  genome  and,  in  addition,  to  begin  the  development  of an  inbred  strain 
expressing the synergistic defect. As shown  in Table VII, a  CBA/N  female crossed  to 
a  BC.1  SD  +  male  gives  rise  to  male  and  female  progeny,  referred  to  as  reverse 
backcross  (RBC)  mice, which  are F-  as expected, because  the mother is homozygous 
and  the father  hemizygous  for the xid gene.  Both  RBC  males were SD  +. Of the four 
females, two responded  normally to TNP-BA,  LPS K235, and LPS 0111 :B4, and two 
responded  poorly. The latter were classed as SD  p. One SD  p female and one SD  + male 
RBC  mouse were intercrossed,  before their typing, to yield intercross  (IC). 1 mice. All 
of the IC. 1 mice were F-, two  (one male and one female) were SD  + and  several were 
SD  p.  An  SD  p  IC.1  male  was  crossed  to  an  SD  p  IC.1  female.  All  the  IC.2  progeny 
expressed  some  SD  and  one-half expressed  the  SD  +  phenotype.  Two  litters  of IC.3 
mice were studied.  All expressed  an SD phenotype.  This suggests that  a  gene or genes 
from the C3H  background  has been  fixed in the intercrossed  animals  and  is required 
for the expression  of the SD. 
Discussion 
We have shown  here that  the  introduction  of the xid gene, in a  hemizygous  form, 
into  the C3H  genetic environment  leads  to  a  more profound  immune  defect  than  is 
expressed by either the CBA/N  mouse or the C3H/HeJ  mouse. This synergistic defect, 
in  its  full  form,  it  characterized  by  unresponsiveness  to  a  series  of  B-lymphocyte 
mitogens  and  by  a  failure  to  respond,  in  vitro,  to  TI-1  as  well  as  TI-2  antigens.  A 
partial form of the synergistic defect also occurs, generally characterized by unrespon- 
siveness to B-cell mitogens and  by weak responses  to TI-1  antigens. 232  SYNERGISTIC B-CELL DEFECT 
The nature of the C3H genes involved in the expression of the SD phenotype is not 
known  but  the  Lps a  gene  is  not  required  although  it  is  possible  that  this  gene 
contributes to the defect. The finding that the SD  ÷ phenotype can be established in 
intercrossed  mice  resulting  from  a  cross of a  BC.1  SD  + male  mouse  to  a  CBA/N 
female strongly suggests that the C3H influence is genetic rather than environmental 
in nature. Whether the difference between the SD  p and SD  + phenotypes is simply one 
of penetrance or reflects the action of two distinct C3H genes is not known. 
The establishment of strains of mice with the SD phenotype should shed consider- 
able  light  on  the  ontogeny,  heterogeneity,  and  function  of B  lymphocytes.  The 
CBA/N defect had been considered to reflect either a  maturation arrest  in a  single 
lineage  of B  lymphocytes or  a  defect  limited  to  one  of two  lines  (1).  The  latter 
interpretation is supported bydata from Kincade (20) and Johnson et al.  (21) which 
indicate  that  CBA/N  mice  are  defective  in  a  B-eel[  function  which  is  normally 
expressed  as early as  17  d  of fetal  life,  namely the capacity to  form B-lymphocyte 
colonies  in  agar.  If the  CBA/N defect  is  thought  of as  a  deletion  or  a  very early 
developmental arrest in one of two B-lymphocyte sublines, then responsiveness to TI- 
1 antigens would,  most  logically, be  a  function of the  alternative  cell  line because 
CBA/N mice respond quite well to these antigens. The finding that the introduction 
of the xid gene into the C3H genetic background leads to the SD phenotype, in which 
there is no responsiveness to TI-1 antigens, would then require that the SD involved 
both B-cell sublines. An alternative possibility is that responsiveness to TI-1 antigens 
is  a  very primitive  function  of the  subline  which  will  eventually  respond  to  TI-2 
antigens  and  that  the  synergizing C3H  genes  cause  the  maturation  arrest  in  that 
subline to occur at an even earlier stage than that at which TI- 1 antigen responsiveness 
is acquired. 
The effect of the SD on TD responses had not been  fully evaluated.  The finding 
that secondary responses to DNP-KLH are not obviously altered does not exclude the 
possibility that serious abnormalities in other TD responses may occur. Until a  more 
complete study of TD responses in mice with SD phenotype has been carried out, it 
would  be  premature  to  attempt  to  place  responsiveness  to  TD  antigens  in  this 
developmental scheme. These issues  should be possible to address when inbred and 
congenic lines expressing the SD phenotype are available. We are currently preparing 
two such lines. 
Our results  could be restated  to say that  in  the presence of the synergizing C3H 
genes(s),  the immunologic defect caused by the xid gene is much more profound than 
that observed in CBA/N mouse. In a sense,  the clinical syndrome exhibited by BC. 1 
male mice is much more severe than that exhibited by CBA/N mice or by F1 males 
from  crosses  between  CBA/N  females  and  DBA/2,  BALB/c,  or  C57BL/6  males, 
although all these mice possess  the same defective X  chromosomal gene. This raises 
the possibility that distinct human X-linked immunodeficiency diseases  (e.g., X-linked 
agammaglobulinemia, severe combined immunodeficiency, and Wiskott-Aldrich syn- 
drome) may not all involve distinct defective X chromosomal genes. Rather, the same 
X chromosomal gene in different autosomal genetic environments might lead to quite 
distinct immunologic deficiencies. 
Summary 
CBA/N female mice, which express an X-linked defect in B-lymphocyte function, 
were mated with C3H/HeJ male mice, which are unresponsive to lipopolysaccharide CONSTANTIN BONA, JAMES J.  MOND,  AND WILLIAM E.  PAUL  233 
(LPS).  The  resulting  F1  hybrid  females were  mated  to  C3H/HeJ  males.  Approxi- 
mately one-half of the backcross (BC. 1) males obtained from this mating expressed a 
more profound  immunologic defect than  either of the parental strains.  Spleen cells 
from  these  mice  were  unresponsive  to  a  series  of  B-cell  mitogens  including  LPS 
prepared  from  Escherichia  coli  K235  and  from  E.  coll  0111:B4,  lipoprotein  mitogen 
from E.  coli,  and  Nocardia water-soluble mitogen  (NWSM).  They  failed to give in 
vitro antibody responses to the thymus-independent type 2  (TI-2) antigen trinophen- 
ylated  Ficoll and  most  were  unresponsive  to  the  TI-1  antigens  trinitrophenylated 
Brucella abortus,  trinitrophenylated LPS, and trinitrophenylated NWSM. This syner- 
gistic defect in B-lymphocyte function depended on the presence of the CBA/N  xid 
gene  but  the  critical gene(s)  from  the  C3H  strain  was  not  the  defective Lps  gene 
(Lpsa). These mice should provide a  valuable tool for the elucidation of B-lymphocyte 
ontogeny, heterogeneity, and function. 
We thank Mrs. Shirley House for expert technical assistance. 
Received  for publication l l June 1979 
References 
1.  Paul, W. E., B. Subbarao, J. J. Mond, D. G. Sieckmann, I. Zitron, A. Ahmed, D. E. Mosier, 
and  I.  Scher.  1979.  B  lymphocyte development and  activation: analysis with a  mutant 
mouse strain. In Cells of Immunoglobulin Synthesis. B.  Pernis and H. J.  Vogel, editors. 
Academic Press, Inc., New York. 383. 
2.  Scher, I., A. Ahmed, D. M.  Strong, A. D.  Steinberg, and W. E.  Paul.  1975. X-linked B- 
lymphocyte immune defect in CBA/N mice. I. Studies of the function and composition of 
spleen cells.J. Exp.  Med.  141:788. 
3.  Mosier, D. E., I. M. Zitron, J. J. Mond, A. Ahmed, I. Scher, and W. E. Paul. 1977. Surface 
immunoglobulin D  as a functional receptor for a subclass of B lymphocytes. Immunol. Rev. 
37:89. 
4.  Mosier, D. E., I. Scher, and W. E. Paul.  1976. In vitro responses of CBA/N mice. Spleen 
cells of mice with an X-linked defect that precludes immune responses to several thymus 
independent antigens can respond to TNP-lipopolysaccharide.  J. ImmunoL 117:1336. 
5.  Mond, J. J.,  I.  Scher,  D.  E.  Mosier, M.  Blaese, and  W.  E.  Paul.  1978. T-independent 
responses in  B  cell defective CBA/N  mice to Bmcdla  abortus and  to TNP  conjugates of 
Brucella abortus. Eur. J. Immunol. 8:459. 
6.  Bona, C.  1979. Modulation of immune responses by Nocardia immunostimulants.  Prog. 
Allergy. 26:37. 
7.  Finkelman,  F.  D.,  A.  H.  Smith,  I.  Scher,  and  W.  E.  Paul.  1975. Abnormal  ratio  of 
membrane immunoglobulin classes in mice with an X-linked B-lymphocyte defect.J. Exp. 
Med.  142:1316. 
8.  Huber, B., R. K. Gershon, and H. Cantor.  1977. Identification of a B-cell surface structure 
involved in antigen-dependent triggering: absence of this structure on B cells from CBA/N 
mutant mice.J. Exp.  Med.  145:10. 
9.  Ahmed, A., I. Scher, S. O. Sharrow, A. H. Smith, W. E. Paul, D. H. Sachs, and K. W. Sell. 
1977. B lymphocyte heterogeneity: development and characterization of an alloantiserum 
which distinguishes B-lymphocyte differentiation alloantigens. J. Exp.  Med.  145:101. 
10.  Subbarao, B.,  A. Ahmed, W. E.  Paul, I. Scher, R.  Lieberman, and  D.  E.  Mosier.  1979. 
Lyb7 a  B  cell alloantigen controlled by genes linked to the IgCH locus. J.  ImmunoL  122: 
2279. 
11.  Watson, J., and R. Riblet. 1975. Genetic control to bacterial polysaceharide in mice. II. A 
gene that  influences a  membrane component  involved in the activation of bone-marrow 234  SYNERGISTIC  B-CELL  DEFECT 
derived lymphocytes by polysaccharide.  J. lrnmunoL 114:1662. 
12.  Watson, J., K. Kelly, M. Largen, and B. A. Taylor. 1978. The genetic mapping of defective 
LPS response gene in C3H/HeJ mice.J. Immunol.  120:422. 
13.  Bona,  C.  1976. Resemblance  of blast  response  of C3H/HeJ  mouse  and  rabbit  spleen 
lymphocytes to B-cell mitogenic components of E. coli cell walls, lrnmunol. Comrnun. 5:37. 
14.  McGhee, J. R., J. J. Farrar, S. M. Michalela, S. E. Mergenhagen, and D. L. Rosenstreich. 
1979. Cellular requirements for lipopolysaccharide activity. A role for both T  lymphocytes 
and macrophages for in vitro responses to particulate antigens.J. Exp. Med.  149:793. 
15.  Inman, J.  K.  1975. Thymus-independent  antigens:  the  preparation of covalant, hapten 
Ficoll conjugates. J. Irnmunol. 114:704. 
16.  Chien,  C.  C.,  R.  Lieberman,  and  J.  K.  Inman.  1979. Preparation  of  functionalized 
derivatives of inulin: conjugation of erythrocytes for hemagglutination and plaque-forming 
assay. J. ImmunoL Methods. 26:39. 
17.  Bona, C., and W. E. Paul. 1979. Cellular basis of regulation of expression of idiotype. I. T- 
suppressor cells specific for MOPC  460  idiotype regulate the expression of cells secreting 
anti-TNP antibodies bearing 460 idiotype.J. Exp. Med.  149:542. 
18.  Westpha!, O.,  O.  Luderitz, and  B.  Bister.  1952. Uber die extraction yon Bakterien mit 
Phenol/Wasser. Z. Nati~?forsch. Sect. C. Biosci. 7:148. 
19.  Ciorbaru, R., A. Adam, J. F. Petit, E. Lederer, C. Bona, and L. Chedid.  1975. Isolation of 
mitogenic and adjuvant active fractions from various species of Nocardiae. Infect. Immun. 
11:257. 
20.  Kincade, P.  N.  1977. Defective colony formation by B  lymphocytes from  CBA/N  and 
C3H/HeJ mice.J. Exp. Med.  145:249. 
21.  Johnson, G. R., D. Metcalf, andJ. W. Wilson. 1976. Development of B-lymphocyte colony- 
forming cells in fetal mouse tissues. Immunology. 30:907. 